ClearBridge LLC (Maryland)’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$11.6M	Buy	119,295 +9,545	+9%	+$1.13M	3.53%	5
2018 Q3	$15.3M	Sell	109,750 -709,383	-87%	-$89M	3.74%	5
2018 Q2	$798	Sell	819,133 -28,365	-3%	-$3.32M	0.01%	140
2018 Q1	$94.5M	Buy	847,498 +217,043	+34%	+$25.9M	2.1%	6
2017 Q4	$75.4M	Sell	630,455 -227	-0%	-$27.6K	1.57%	19
2017 Q3	$88.5M	Sell	630,682 -196,158	-24%	-$26.7M	1.91%	11
2017 Q2	$101M	Buy	826,840 +149,780	+22%	+$17.4M	2.13%	10
2017 Q1	$82.1M	Sell	677,060 -12,817	-2%	-$1.65M	1.77%	17
2016 Q4	$84.4M	Buy	689,877 +308	+0%	+$37.7K	1.91%	17
2016 Q3	$84.5M	Buy	689,569 +98,670	+17%	+$12.7M	1.61%	29
2016 Q2	$69M	Buy	590,899 +216,185	+58%	+$30.7M	1.37%	37
2016 Q1	$52.2M	Sell	374,714 -390	-0.1%	-$57.3K	1.03%	42
2015 Q4	$71.6M	Sell	375,104 -11,170	-3%	-$1.95M	1.37%	34
2015 Q3	$60.4M	Sell	386,274 -90,820	-19%	-$16.6M	1.23%	37
2015 Q2	$86.2M	Buy	+477,094	New	+$82.3M	1.54%	32